Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
Director departure
|
|
Viveon Health Acquisition Corp.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/25/2023 |
8-K
| Quarterly results |
| 04/06/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 02/03/2023 |
8-K
| Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive ... |
| 12/28/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 12/22/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"VIVEON HEALTH ACQUISITION CORP. Announces that Redemption Reversals in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Are Extended Until December 23, 2022. NEW YORK, Dec. 21, 2022 -- Viveon Health Acquisition Corp. , a special purpose acquisition company , today announced that it will allow those holders of shares of the Company’ s common stock sold as part of the units issued in its initial public offering who elected to redeem their common stock in connection with the special meeting of stockholders held today at 10:30 AM EST , to reverse their redemption requests by sending a DTC DWAC request to the Company’ s transfer agent, Continental Stock Transfer & Trust Company, by 5:00 PM EST on Friday, December 23, 2022. In connection with the Spec..." |
|
| 08/16/2022 |
8-K
| Quarterly results |
| 07/13/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
8-K
| Quarterly results |
| 03/24/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 03/18/2022 |
8-K
| Quarterly results |
| 03/17/2022 |
8-K
| Quarterly results |
| 02/09/2022 |
8-K
| Quarterly results |
| 01/13/2022 |
8-K
| Investor presentation, Director compensation was amended/approved |
| 11/16/2021 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review  ... |
| 07/02/2021 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review |
| 05/28/2021 |
8-K
| Quarterly results |
| 04/30/2021 |
8-K
| Quarterly results |
| 04/26/2021 |
8-K
| Quarterly results |
| 02/02/2021 |
8-K
| Quarterly results |
| 01/04/2021 |
8-K
| Quarterly results |
| 12/29/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...|
Docs:
|
"Underwriting Agreement, by and between the Company and Chardan Capital Markets, LLC",
"Amended and Restated Certificate of Incorporation",
"Warrant Agreement, by and between Continental Stock Transfer & Trust Company and the Company",
"Rights Agreement, by and between the Company and Continental Stock Transfer & Trust Company;",
"Letter Agreements, among the Company and the Company’ s officers, directors and Initial Stockholders",
"Investment Management Trust Agreement, by and between Continental Stock Transfer & Trust Company and the Company",
"Registration Rights Agreement, by and between the Company and Initial Stockholders",
"A Private Placement Warrants Subscription Agreement, by and between the Company and Viveon Health, LLC;",
"Stock Escrow Agreement, among the Company, Continental Stock Transfer & Trust Company and the Initial Stockholders",
"Indemnity Agreements, by and among the Company and the directors and officers of the Company" |
|
|
|